To define the capacity of colorectal cancer organoids to mirror the genome heterogeneity of the corresponding patient tumor, we compared the mutational status of three genes (KRAS, NRAS, and BRAF) in 19 PDTOs and corresponding tumor tissues. This evidence concerns the gene KRAS and neoplasm.